VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,357,000 | +150.1% | 231,179 | +322.8% | 0.08% | +159.4% |
Q3 2016 | $1,342,000 | -31.7% | 54,679 | -44.0% | 0.03% | -22.0% |
Q2 2016 | $1,966,000 | +142.4% | 97,627 | +216.7% | 0.04% | +78.3% |
Q1 2016 | $811,000 | -24.8% | 30,824 | +190.3% | 0.02% | +27.8% |
Q4 2015 | $1,079,000 | -83.6% | 10,618 | -71.2% | 0.02% | -83.3% |
Q3 2015 | $6,580,000 | +44.2% | 36,890 | +79.6% | 0.11% | +31.7% |
Q2 2015 | $4,563,000 | +552.8% | 20,541 | +483.6% | 0.08% | +485.7% |
Q1 2015 | $699,000 | +183.0% | 3,520 | +105.1% | 0.01% | +250.0% |
Q4 2014 | $247,000 | -14.8% | 1,716 | -22.5% | 0.00% | -33.3% |
Q3 2014 | $290,000 | -93.6% | 2,214 | -93.6% | 0.01% | -89.5% |
Q1 2014 | $4,562,000 | +6.9% | 34,599 | -4.8% | 0.06% | +21.3% |
Q4 2013 | $4,267,000 | -93.4% | 36,346 | -94.2% | 0.05% | -94.3% |
Q3 2013 | $65,082,000 | – | 623,817 | – | 0.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |